Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. | Breast Cancer Res | 2022 | 35850772 | PubTator, text mining | PubMed |
| Antileukemic effects of topoisomerase I inhibitors mediated by de-SUMOylase SENP1. | Biochim Biophys Acta Mol Basis Dis | 2022 | 35850175 | PubTator, text mining | PubMed |
| Think Beyond Particle Cytotoxicity: When Self-Cellular Components Released After Immunogenic Cell Death Explain Chronic Disease Development. | Front Toxicol | 2022 | 35846433 | PubTator, text mining | PubMed |
| DeepND: Deep multitask learning of gene risk for comorbid neurodevelopmental disorders. | Patterns (N Y) | 2022 | 35845835 | PubTator, text mining | PubMed |
| TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity. | Int J Biol Sci | 2022 | 35844787 | PubTator, text mining | PubMed |
| Transcription-associated DNA DSBs activate p53 during hiPSC-based neurogenesis. | Sci Rep | 2022 | 35840793 | PubTator, text mining | PubMed |
| A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells. | Exp Hematol Oncol | 2022 | 35831896 | PubTator, text mining | PubMed |
| Detection of cell markers from single cell RNA-seq with sc2marker. | BMC Bioinformatics | 2022 | 35831796 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| CDK7 Inhibition Synergizes with Topoisomerase I Inhibition in Small Cell Lung Cancer Cells by Inducing Ubiquitin-Mediated Proteolysis of RNA Polymerase II. | Mol Cancer Ther | 2022 | 35830858 | PubTator, text mining | PubMed |
| Resolution of R-loops by topoisomerase III-β (TOP3B) in coordination with the DEAD-box helicase DDX5. | Cell Rep | 2022 | 35830799 | PubTator, text mining | PubMed |
| ScRNA-seq expression of IFI27 and APOC2 identifies four alveolar macrophage superclusters in healthy BALF. | Life Sci Alliance | 2022 | 35820705 | PubTator, text mining | PubMed |
| Sacituzumab govitecan in triple-negative breast cancer. | Ann Transl Med | 2022 | 35813338 | PubTator, text mining | PubMed |
| Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma. | Front Immunol | 2022 | 35812404 | PubTator, text mining | PubMed |
| Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy. | Kidney Int Rep | 2022 | 35812291 | PubTator, text mining | PubMed |
| DetectFormer: Category-Assisted Transformer for Traffic Scene Object Detection. | Sensors (Basel) | 2022 | 35808332 | PubTator, text mining | PubMed |
| Research on the Policy Effect and Mechanism of Carbon Emission Trading on the Total Factor Productivity of Agricultural Enterprises. | Int J Environ Res Public Health | 2022 | 35805258 | PubTator, text mining | PubMed |
| Determination of human DNA replication origin position and efficiency reveals principles of initiation zone organisation. | Nucleic Acids Res | 2022 | 35801867 | PubTator, text mining | PubMed |
| Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS/STING pathway. | Br J Cancer | 2022 | 35794238 | PubTator, text mining | PubMed |
| Genetic dissection of non-syndromic retinitis pigmentosa. | Indian J Ophthalmol | 2022 | 35791117 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=49